Clinical trials
Thrombocythemia, Essential trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 7 |
| Completed | 7 |
| Recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 4 |
| PharmaEssentia | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Sierra Oncology LLC - a GSK company | 2 |
| University Health Network, Toronto | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| CTI BioPharma | 1 |
| Constellation Pharmaceuticals | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| NCIC Clinical Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 20 |
| Myeloproliferative Disorders | 15 |
| Primary Myelofibrosis | 13 |
| Polycythemia Vera | 12 |
| Hematologic Diseases | 6 |
| Bone Marrow Diseases | 5 |
| Myelodysplastic Syndromes | 4 |
| Thrombocytosis | 4 |
| Hemorrhagic Disorders | 3 |
| Leukemia | 3 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.